BIEL — BioElectronics Share Price
Last trade - 00:00- $4.94m
- $18.28m
- $1.61m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | n/a | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 3.07 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | n/a | ||
| Return on Equity | n/a | ||
| Operating Margin | -9.6% | ||
Financial Summary
| Year End 31st Dec | Unit | 2017 | 2018 | 2019 | 2020 | 2021 | 2022E | 2023E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 1.76 | 1.05 | 0.94 | 0.83 | 1.61 | n/a | n/a | -5.09% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
BioElectronics Corporation is an electroceutical company. It develops wearable, neuromodulation devices to safely mitigate neurological diseases and enhance quality of life. Its flagship product, the ActiPatch Musculoskeletal Pain Therapy, is developed to relieve chronic pain. The Company’s pulsed shortwave therapy technology (PSWT) that uses low power pulsed electromagnetic fields regulate electrical activity of the nervous system. Its product line includes ActiPatch Musculoskeletal Pain Therapy, and RecoveryRx Post-operative and Chronic Wounds Therapy, which are sold by or on the order of medical professionals. ActiPatch is a drug-free, wearable nonprescription medical device that provides 720-hours (90, 8-hour treatments) of on/off therapy. The ActiPatch is indicated for the treatment of general musculoskeletal/soft-tissue pain, while the RecoveryRx is indicated for the treatment of postoperative pain. It is focused on international customers to expand its distributions and sales.
Directors
- Richard Staelin CHM (74)
- Kelly Whelan PRE
- Keith Nalepka VPR
- John Martinez VPR
- William Monn VPR
- Ben Fichter OTH
- Ian Rawe OTH
- Mary Whelan DRC (57)
- Last Annual
- December 31st, 2021
- Last Interim
- December 31st, 2021
- Incorporated
- April 10th, 2000
- Public Since
- April 12th, 2004
- No. of Employees
- 9
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
- Pink Sheets on Nasdaq
- Shares in Issue
- 24,705,066,971
- Address
- 4539 Metropolitan Ct, FREDERICK, 21704-9452
- Web
- https://www.bielcorp.com/
- Phone
- +1 3018744890
- Contact
- Paul Knopick
- Auditors
- Berenfeld, Spritzer, Shechter & Sheer
Upcoming Events for BIEL
Similar to BIEL
Aamaxan Transport
Pink Sheets on Nasdaq
ACCUSTEM SCIENCES
Pink Sheets on Nasdaq
Acutus Medical
Pink Sheets on Nasdaq
ADM Tronics Unlimited
Pink Sheets on Nasdaq
Advanced Biomedical Technologies
Pink Sheets on Nasdaq
FAQ
As of Today at 19:35 UTC, shares in BioElectronics are trading at $0.00. This share price information is delayed by 15 minutes.
Shares in BioElectronics last closed at $0.00 and the price had moved by +100% over the past 365 days. In terms of relative price strength the BioElectronics share price has outperformed the S&P500 Index by +85.45% over the past year.
There is no consensus recommendation for this security.
Find out moreBioElectronics does not currently pay a dividend.
BioElectronics does not currently pay a dividend.
BioElectronics does not currently pay a dividend.
To buy shares in BioElectronics you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of $0.00, shares in BioElectronics had a market capitalisation of $4.94m.
Here are the trading details for BioElectronics:
- Country of listing: United States
- Exchange: PNK
- Ticker Symbol: BIEL
Based on an overall assessment of its quality, value and momentum BioElectronics is currently classified as a . The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like BioElectronics. Over the past six months, its share price has outperformed the S&P500 Index by +0.27%.
As of the last closing price of $0.00, shares in BioElectronics were trading -20.16% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The BioElectronics PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $0.00.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
BioElectronics' management team is headed by:
- Richard Staelin - CHM
- Kelly Whelan - PRE
- Keith Nalepka - VPR
- John Martinez - VPR
- William Monn - VPR
- Ben Fichter - OTH
- Ian Rawe - OTH
- Mary Whelan - DRC